🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, asserting the corporations withheld potential risks that the drug created to children's brain development.

The lawsuit arrives four weeks after Donald Trump advocated an unproven link between taking Tylenol - referred to as paracetamol - throughout gestation and autism spectrum disorder in young ones.

Paxton is taking legal action against J&J, which formerly manufactured the medication, the only pain reliever recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he stated they "betrayed America by profiting off of pain and marketing drugs regardless of the dangers."

Kenvue asserts there is lacking scientific proof linking Tylenol to autism.

"These manufacturers deceived for years, intentionally threatening millions to boost earnings," the attorney general, from the Republican party, declared.

The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its official site, Kenvue also mentioned it had "consistently assessed the relevant science and there is no credible data that shows a verified association between consuming acetaminophen and autism."

Organizations acting on behalf of doctors and healthcare providers concur.

ACOG has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for expectant mothers to manage pain and elevated temperature, which can create major wellness concerns if not addressed.

"In over twenty years of studies on the use of paracetamol in gestation, not a single reputable study has definitively established that the consumption of paracetamol in any period of gestation results in neurological conditions in children," the organization stated.

The court filing cites current declarations from the former administration in claiming the medication is allegedly unsafe.

Last month, Trump generated worry from public health officials when he instructed pregnant women to "fight like hell" not to consume Tylenol when ill.

Federal regulators then released a statement that medical professionals should think about restricting the consumption of acetaminophen, while also declaring that "a direct connection" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Kennedy, who oversees the FDA, had pledged in April to initiate "comprehensive study program" that would determine the origin of autism spectrum disorder in a short period.

But experts advised that discovering a unique factor of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of inherited and external influences - would not be simple.

Autism is a type of enduring cognitive variation and disability that influences how persons perceive and relate to the world, and is recognized using medical professional evaluations.

In his legal document, Paxton - who supports Trump who is seeking the Senate - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

The case aims to force the corporations "eliminate any promotional materials" that claims acetaminophen is secure for expectant mothers.

This legal action mirrors the grievances of a collection of parents of minors with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in two years ago.

The court threw out the lawsuit, saying research from the parents' expert witnesses was inconclusive.